Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood

European Journal of Pharmacology

Volumn 538, Issue 1-3, 2006, Pages 188-194

  Ahmad, Syahida ^a   Israf, Daud A ^a   Lajis, Nordin Hj ^a   Shaari, Khozirah ^a   Mohamed, Habsah ^b   Wahab, Afiza A ^a   Ariffin, Khaizurin T ^a   Hoo, Wei Yee ^a   Aziz, Nasaruddin A ^a   Kadir, Arifah A ^a   Sulaiman, Mohamad R ^a   Somchit, Muhammad N ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITI MALAYSIA TERENGGANU   (Malaysia)

Author keywords

Alpinia rafflesiana; Cardamonin; Inflammatory mediator; RAW 264.7; Whole blood

Indexed keywords

2',4' DIHYDROXY 6' METHOXYCHALCONE; CARDAMONIN; CHALCONE DERIVATIVE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; LIPOXYGENASE; NITRIC OXIDE; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; THROMBOXANE B2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALPINIA; ALPINIA RAFFLESIANA; ANIMAL CELL; ARTICLE; BLOOD; CELL STRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; IC 50; INHIBITION KINETICS; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CELL SURVIVAL; CHALCONES; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; HUMANS; INFLAMMATION MEDIATORS; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; LIPOXYGENASE; MACROPHAGES; MICE; MOLECULAR STRUCTURE; MONOCYTES; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; THROMBOXANE B2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646533752     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.03.070     Document Type: Article

References (32)

1. Anto R.J., Sukumaran K., Kuttan G., Rao M.N., Subbaraju V., and Kuttan R. Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Lett. 97 (1995) 33-37
2. Ban H.S., Suzuki K., Lim S.S., Jung S.H., Lee S., and Ji J. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase and tumor necrosis factor-a by 2′-hydroxychalcone derivatives in RAW 264.7 cells. Biochem. Pharmacol. 67 (2004) 1549-1557
3. Bheemasankara R.C., Namosiva R.T., and Suryaprakasam S. Cardamonin and alpinetin from the seeds of Amomum subulatum. Planta Med. 29 (1976) 391-392
4. Bley K.R., Hunter J.C., Eglen R.M., and Smith J.A.M. The role of IP prostanoid receptors in inflammatory pain. Trends Pharmacol. Sci. 19 (1998) 141-147
5. Bors W., Heller W., Michel C., and Saran M. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Meth. Enzymol. 186 (1990) 343-355
6. Burkill I.H. A Dictionary of the Economic Products of the Malay Peninsula vol. 2 (1966), Ministry of Agriculture and Co-operatives, Kuala Lumpur, Malaysia 1323
7. Busse W.W., Kopp D.E., and Middleton Jr. E. Flavonoid modulation of human neutrophil function. J. Allergy Clin. Immunol. 73 (1984) 801-809
8. Chen S.C., Chang Y.S., Wang J.P., Chen S.C., and Kuo S.C. Three new flavonoids and antiallergenic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera. Planta Med. 64 (1998) 153-158
9. Cheng Z.J., Lin C.N., Hwang T.L., and Teng C.M. Broussochalcone A, a potent antioxidant and effective suppressor of inducible nitric oxide synthase in lipopolysaccharide-activated macrophages. Biochem. Pharmacol. 61 (2001) 939-946
10. Cryer B., and Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am. J. Med. 104 (1998) 413-421
11. Dirsch V.M., Stuppner H., and Vollmar A.M. The Griess assay: suitable for a bio-guided fractionation of anti-inflammatory plant extracts?. Planta Med. 64 (1998) 423-426
12. Herencia F., Ferrandiz M.L., Ubeda A., Dominguez J.N., Charris J.E., Lobo G.M., and Alcaraz M.J. Synthesis and anti-inflammatory activity of chalcone derivatives. Bioorg. Med. Chem. Lett. 8 (1998) 1169-1174
13. Herencia F., Ferrandiz M.L., Ubeda A., Guillen I., Dominguez J.N., Charris J.E., Lobo G.M., and Alcaraz M.J. Novel anti-inflammatory chalcone derivatives inhibit the induction of nitric oxide synthase and cyclooxygenase-2 in mouse peritoneal macrophages. FEBS Lett. 453 (1999) 129-134
14. Herencia F., Lopez M.P., Ubeda A., and Ferrandiz M.L. Nitric oxide-scavenging properties of some chalcone derivatives. Nitric Oxide 6 (2002) 242-246
15. Huang Y.C., Guh J.H., Cheng Z.J., Chang Y.L., Hwang T.L., Lin C.N., and Teng C.M. Inhibitory effect of DCDC on lipopolysaccharide-induced nitric oxide synthesis in RAW 264.7 cells. Life Sci. 68 (2001) 2435-2447
16. 2 production by 2′-hydroxychalcone derivatives and the mechanism of action. J. Pharm. Pharmacol. 53 (2001) 1295-1302
17. Ko H.K., Tsao L.T., Yu K.L., Liu C.T., Wang J.P., and Lin C.N. Structure-activity relationship studies on chalcone derivatives: the potent inhibition of chemical mediator release. Bioorg. Med. Chem. 11 (2003) 105-111
18. Lopez S.N., Castelli M.V., Zacchino S.A., Dominguez J.N., Lobo G., Charris-Charris J., Cortes J.C., Ribas J.C., Devia C., Rodriguez A.M., and Enriz R.D. In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues with inhibitory properties against polymers of the fungal wall. Bioorg. Med. Chem. 9 (2001) 1999-2013
19. Marriot J.B., Westby M., and Dalgleish A.G. Therapeutic potential of TNF-α inhibitors old and new. Drug Discov. Today 2 (1997) 273-282
20. Middleton Jr. E., and Drzewiecki G. Flavonoid inhibition of human basophil histamine release stimulated by various agents. Biochem. Pharmacol. 33 (1984) 3333-3338
21. Mohamad H., Faridah A., Permana D., Lajis N.H., Ali A.M., Sukari M.A., Hin T.Y.Y., Kikuzaki H., and Nakatani N. DPPH free radical scavenger components from the fruits of Alpinia rafflesiana Wall. ex. Bak. (Zingiberaceae). Z. Naturforsch. 59c (2004) 811-815
22. Morel Y., and Barouki R. Repression of gene expression by oxidative stress. Biochem. J. 342 (1999) 481-496
23. Nakadate T., Aizu E., Yamamoto S., and Kato R. Effects of chalcone derivatives on lipoxygenase and cyclooxygenase activities of mouse epidermis. Prostaglandins 30 (1997) 357-368
24. Piette J., Piret B., Bonizzi G., Schoonbroodt S., Merville M.P., Legrand-Poels S., and Bours V. Multiple redox regulation in NF-kappaB transcription factor activation. Biol. Chem. 378 (1997) 1237-1245
25. Prasain J.K., Yasuhiro T., Jian X.L., Ken T., Purusotam B., Hui D., Namba T., and Kadota S. Six novel diarylheptanoids bearing chalcone or flavanone moiety from the seeds of Alpinia blepharocalyx. Tetrahedron 53 (1997) 7833-7842
26. Sen C.K., and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10 (1996) 709-720
27. Trakoontivakorn G., Nakahara K., Shinmoto H., Takenaka M., Onishi-Kameyama M., Ono H., Yoshida M., Nagata T., and Tsushida T. Structural analysis of a novel antimutagenic compound, 4-Hydroxypanduratin A, and the antimutagenic activity of flavonoids in a Thai spice, fingerroot (Boesenbergia pandurata Schult.) against mutagenic heterocyclic amines. J. Agric. Food Chem. 49 (2001) 3046-3050
28. Wang H., and Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. J. Free Radic. Biol. and Med. 27 (1999) 612-616
29. Wang Z.T., Lau C.W., Chan F.L., Yao X., Chen Z.Y., He Z.D., and Huang Y. Vasorelaxant effects of cardamonin and alpinetin from Alpinia henryi K. Schum. J. Cardiovasc. Pharmacol. 37 (2001) 596-606
30. Won S.J., Liu C.T., Tsao L.T., Weng J.R., Ko H.H., Wang J.P., and Lin C.N. Synthetic chalcones as potential anti-inflammatory and cancer chemopreventive agents. Eur. J. Med. Chem. 40 (2005) 103-112
31. Yao J., Mackman N., Edgington T.S., and Fan S.T. Lipopolysaccharide induction of the tumour necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J. Biol. Chem. 272 (1997) 17795-17801
32. Zhao F., Nozawa H., Daikonnya A., Kondo K., and Kitanaka S. Inhibitors of nitric oxide production from Hops (Humulus lupulus L.). Biol. Pharm. Bull. 26 (2003) 61-65